Wai Yuen Tong Medicine Holdings Limited (0897.HK)
HKD 0.21
(-0.48%)
HKD 0.21
(-0.48%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 783.88 Million | 1.28 Billion | 1.39 Billion | 1.1 Billion | 620.74 Million | 751.44 Million |
| Cost of Revenue | 389.06 Million | 676.88 Million | 817.25 Million | 660.3 Million | 338.5 Million | 449.91 Million |
| Gross Profit | 394.81 Million | 609.54 Million | 574.15 Million | 448.25 Million | 282.23 Million | 301.52 Million |
| Operating Expenses | 353.93 Million | 557.98 Million | 517.99 Million | 471.58 Million | 416.67 Million | 290.36 Million |
| Selling, General and Administrative Expenses | 352.14 Million | 544.6 Million | 516.65 Million | 467.25 Million | 405.8 Million | 448.66 Million |
| Research and Development Expenses | 1.78 Million | 1.89 Million | 1.3 Million | 4.97 Million | 10.84 Million | 7.9 Million |
| Other Expenses | - | -11.48 Million | -31 Thousand | 646 Thousand | -30 Thousand | 9.2 Million |
| Cost and Expenses | 743 Million | 1.23 Billion | 1.33 Billion | 1.13 Billion | 755.18 Million | 740.28 Million |
| Operating Income | 40.88 Million | 51.55 Million | 56.16 Million | -23.32 Million | -134.43 Million | -147.13 Million |
| Interest Expense | 40.79 Million | 106.3 Million | 95.69 Million | 107.72 Million | 52.78 Million | 28.55 Million |
| Income Tax Expense | -6.35 Million | -15.28 Million | 40.51 Million | 148.13 Million | 17.19 Million | 7.44 Million |
| Earnings before Tax | -13.63 Million | -14.88 Million | -48.87 Million | -307.78 Million | 439.99 Million | 81.69 Million |
| Net Income | -15.35 Million | -20.51 Million | -108.91 Million | -375.99 Million | 438.54 Million | 74.62 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.09 | -0.31 | 0.36 | 0.06 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.09 | -0.31 | 0.36 | 0.06 |
| Weighted Average Shares Outstanding | 1.18 Billion | 1.21 Billion | 1.23 Billion | 1.23 Billion | 1.23 Billion | 1.24 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.18 Billion | 1.21 Billion | 1.23 Billion | 1.23 Billion | 1.23 Billion | 1.24 Billion |
| Gross Margin | 0.50 | 0.47 | 0.41 | 0.40 | 0.45 | 0.40 |
| EBIT Margin | 0.15 | 0.13 | 0.12 | 0.06 | -0.04 | -0.13 |
| Profit Margin | -0.02 | -0.02 | -0.08 | -0.34 | 0.71 | 0.10 |
| EBITDA | 113.79 Million | 115.88 Million | 154.61 Million | -107.43 Million | 605.44 Million | 161.57 Million |
| Earnings Before Tax Margin | 0.05 | 0.04 | 0.04 | -0.02 | -0.22 | -0.20 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 105.07 Million | 783.88 Million | 678.8 Million | 680.3 Million | 1.28 Billion | 606.12 Million |
| Cost of Revenue | 51.58 Million | 389.06 Million | 353.57 Million | 343.22 Million | 676.88 Million | 333.66 Million |
| Gross Profit | 53.49 Million | 394.81 Million | 325.23 Million | 337.07 Million | 609.54 Million | 272.46 Million |
| Operating Expenses | 77.58 Million | 353.93 Million | 259.09 Million | 292.29 Million | 557.98 Million | 265.69 Million |
| Selling, General and Administrative Expenses | 77.58 Million | - | 259.05 Million | 285.51 Million | - | 260.99 Million |
| Research and Development Expenses | - | - | - | 1.89 Million | - | - |
| Other Expenses | 1.57 Million | 7.91 Million | -38.99 Thousand | -6.78 Million | -11.48 Million | -4.7 Million |
| Cost and Expenses | 129.16 Million | 743 Million | 612.67 Million | 635.51 Million | 1.23 Billion | 599.36 Million |
| Operating Income | -24.08 Million | 40.88 Million | 66.13 Million | 44.78 Million | 51.55 Million | 6.76 Million |
| Interest Expense | - | 40.79 Million | 57.79 Million | 53.85 Million | 106.3 Million | 52.44 Million |
| Income Tax Expense | -23.66 Million | -6.35 Million | 17.3 Million | -31.9 Million | -15.28 Million | 16.62 Million |
| Earnings before Tax | -53.33 Million | -16.16 Million | 37.16 Million | 4.86 Million | -14.88 Million | -19.74 Million |
| Net Income | -18.9 Million | -15.35 Million | 3.54 Million | 32.86 Million | -20.51 Million | -53.38 Million |
| Earnings Per Share Basic | -0.02 | - | 0.00 | 0.03 | - | -0.04 |
| Earnings Per Share Diluted | -0.02 | - | 0.00 | 0.03 | - | -0.04 |
| Weighted Average Shares Outstanding | 1.17 Billion | 1.18 Billion | 1.19 Billion | 1.2 Billion | 1.21 Billion | 1.22 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.17 Billion | 1.18 Billion | 1.19 Billion | 1.2 Billion | 1.21 Billion | 1.22 Billion |
| Gross Margin | 0.51 | 0.50 | 0.48 | 0.50 | 0.47 | 0.45 |
| EBIT Margin | 0.10 | - | 0.18 | 0.15 | - | 0.10 |
| Profit Margin | -0.18 | -0.02 | 0.01 | 0.05 | -0.02 | -0.09 |
| EBITDA | 10.49 Million | - | 120.72 Million | 101.34 Million | - | 63.25 Million |
| Earnings Before Tax Margin | -0.23 | 0.05 | 0.10 | 0.07 | 0.04 | 0.01 |
600682
CWSRF
TRVR
FXG
DIAMONDYD
EIMCOELECO